In a recent publication,1 Ibberson and I reviewed all (381) cases of carcinoma of the esophagus admitted to the Toronto General Hospital, January, 1937, to December, 1953. We included lesions of the hypopharynx (retrocricoid area) but not other "extrinsic larynx" growths. We were careful to exclude gastric tumors extending into the esophagus. Adenocarcinomas of the lower esophagus were accepted only when their gross characteristics definitely established an esophageal origin. The distribution by sex and site is shown in Table 1.
The survival statistics demonstrated chiefly our failure to control this form of malignant disease (Table 2). Taking the whole group into account, regardless of the kind or completeness of treatment, it was seen that over half were dead within six months, 4 out of 5 died within one year of admission, less than 1 out of 10 lived as long as two years, and only 3 patients out of
MUSTARD RA. Selection of Therapy for Esophageal Cancer. AMA Arch Surg. 1957;75(4):674–679. doi:10.1001/archsurg.1957.01280160184022
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: